Evidence for a digitalis-like substance in the hypothalamopituitary axis in rats: implications in the central cardiovascular regulation associated with an excess intake of sodium.
The origin and the physiological role of an endogenous digitalis-like substance were investigated by measuring both the digoxin-like substance by a digoxin radioimmunoassay (RIA) and the inhibitory activity on the ouabain sensitive Na+,K+-ATPase in rats. The digitalis-like substance was in high concentration in the pituitary, and in decreasing concentration in the hypothalamus, adrenal and the other organs as measured by RIA using an antibody raised from a goat. However, the adrenal showed the highest content of digitalis-like substance as measured by the antibody raised from a rabbit. The plasma level markedly decreased during a 2-week sodium-loading, and the adrenal content decreased markedly on hypophysectomy as measured with the rabbit-antibody. Therefore, the substance measured with the rabbit-antibody must be one of ACTH-dependent adrenal steroids. The inhibitory activity on the Na+,K+-ATPase was high in the pituitary gland, and was decreased in order of the adrenal, hypothalamus and other organs. The 2-week sodium-loading increased both the content in the pituitary gland and the output in the urine, and decreased the hypothalamic content. Immunohistochemical staining of the hypothalamus with the antibody revealed that the immunoreactivity is restricted to the neurons of the paraventricular nucleus, supraoptic nucleus, magnocellular accessory nuclei and extended their fibers reaching to the inner layer of the median eminence. To determine the role of the substance in the brain, the crude extract dissolved in artificial cerebrospinal fluid was injected into the lateral ventricle; vasopressor responses, tachycardia and hyperactivity of the splanchnic nerve lasting for more than 30 min were recorded, which resembled the responses to ouabain injected similarly.(ABSTRACT TRUNCATED AT 250 WORDS)
Takahashi
H
H
2nd Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Matsuzawa
M
M
Okabayashi
H
H
Suga
K
K
Ikegaki
I
I
Yoshimura
M
M
Ijichi
H
H
Okamura
H
H
Murakami
S
S
Ibata
Y
Y
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000008:administration & dosage / Q000032:analysis*; D002298:Cardenolides; D002319:Cardiovascular System / Q000187:drug effects*; D003900:Desoxycorticosterone / Q000009:adverse effects; D004077:Digoxin; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced; D007030:Hypothalamo-Hypophyseal System / Q000032:analysis* / Q000187:drug effects; D007150:Immunohistochemistry; D007276:Injections, Intraventricular; D008297:Male; D010042:Ouabain; D010913:Pituitary-Adrenal System / Q000032:analysis* / Q000187:drug effects; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D012503:Saponins; D012982:Sodium, Dietary / Q000494:pharmacology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000032:analysis* / Q000097:blood
D001798:Blood Proteins; D002298:Cardenolides; D012503:Saponins; D012982:Sodium, Dietary; C034504:digoxin-like factors; D003900:Desoxycorticosterone; D010042:Ouabain; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase